|
Market Closed -
Abu Dhabi Securities Exchange
06:56:11 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 1.040 AED | -0.95% |
|
0.00% | -11.11% |
| 08-14 | Julphar Restarts Trading in Abu Dhabi | MT |
| 08-13 | Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 1.2B 327M 283M 265M 241M 454M 31.28B 461M 3.11B 1.22B 15.66B 1.23B 52.05B | P/E 2026 * |
13x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 951M 259M 224M 210M 191M 359M 24.77B 365M 2.46B 963M 12.4B 973M 41.22B | EV / Sales 2026 * |
0.84x | EV / Sales 2027 * | 0.74x |
| Free-Float |
34.75% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.95% | ||
| 1 month | +0.97% | ||
| 3 months | -3.70% | ||
| 6 months | -12.61% | ||
| Current year | -11.11% |
| 1 week | 1.03 |  | 1.07 |
| 1 month | 1 | | 1.09 |
| Current year | 0.96 | | 1.26 |
| 1 year | 0.96 | | 1.47 |
| 3 years | 0.7 | | 1.78 |
| 5 years | 0.7 | | 2.32 |
| 10 years | 0.7 | | 4.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Basel Ziyadeh
CEO | Chief Executive Officer | - | - |
Khalid Malkawi
DFI | Director of Finance/CFO | - | - |
Malik Metahri
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2016-12-31 | |
| Director/Board Member | - | 2018-12-31 | |
| Chairman | - | 2004-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | 0.00% | -27.78% | +19.40% | 327M | |
| +0.21% | +5.65% | +61.31% | +25.01% | 335B | |
| -2.29% | -5.12% | +21.64% | -15.21% | 68.61B | |
| -2.00% | -4.33% | +46.66% | +124.13% | 11.2B | |
| -1.26% | +1.30% | -2.03% | -4.67% | 8.49B | |
| -0.34% | +2.22% | -13.22% | -8.59% | 4.84B | |
| +1.45% | +3.85% | -26.84% | +16.87% | 4.42B | |
| +0.32% | -2.16% | +0.82% | +45.93% | 4.28B | |
| +2.57% | +1.51% | +13.28% | +51.88% | 2.81B | |
| -1.59% | -2.84% | -4.94% | -3.92% | 2.19B | |
| Average | -0.39% | -0.29% | +6.89% | +25.08% | 44.23B | |
| Weighted average by Cap. | -0.25% | +3.43% | +50.59% | +20.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.13B 308M 266M 250M 227M 428M 29.47B 435M 2.93B 1.15B 14.76B 1.16B 49.04B | 1.22B 332M 287M 270M 245M 461M 31.79B 469M 3.16B 1.24B 15.92B 1.25B 52.9B |
| Net income | - | - |
| Net Debt | -250M -68.06M -58.79M -55.24M -50.24M -94.45M -6.51B -96.01M -647M -253M -3.26B -256M -10.83B | -294M -80.04M -69.13M -64.96M -59.08M -111M -7.65B -113M -761M -298M -3.83B -301M -12.74B |
Employees
2,400
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | AED 1.040 | -0.95% | 586,213 |
| 26-08-13 | AED 1.050 | +1.94% | 1,132,420 |
| 26-08-12 | AED 1.030 | -0.96% | 327,565 |
| 26-08-11 | AED 1.040 | 0.00% | 277,832 |
| 26-08-10 | AED 1.040 | 0.00% | 1,444,490 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.040AED
Average target price
1.560AED
Spread / Average Target
+50.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- JULPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
